[go: up one dir, main page]

EA201600411A1 - Производные пиперидина для применения при лечении или профилактики психиатрических и неврологических состояний - Google Patents

Производные пиперидина для применения при лечении или профилактики психиатрических и неврологических состояний

Info

Publication number
EA201600411A1
EA201600411A1 EA201600411A EA201600411A EA201600411A1 EA 201600411 A1 EA201600411 A1 EA 201600411A1 EA 201600411 A EA201600411 A EA 201600411A EA 201600411 A EA201600411 A EA 201600411A EA 201600411 A1 EA201600411 A1 EA 201600411A1
Authority
EA
Eurasian Patent Office
Prior art keywords
psychiatric
piperidine
prevention
derivatives
treatment
Prior art date
Application number
EA201600411A
Other languages
English (en)
Other versions
EA030729B1 (ru
Inventor
Анне Голдби
Керри Дженкинс
Мартин Тилл
Original Assignee
Такеда Фармасьютикл Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютикл Компани Лимитед filed Critical Такеда Фармасьютикл Компани Лимитед
Publication of EA201600411A1 publication Critical patent/EA201600411A1/ru
Publication of EA030729B1 publication Critical patent/EA030729B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Данное изобретение предлагает соединения формулы (I) и их фармацевтически приемлемые солив которой R, R, R, Rи Rявляются такими, как определено в описании, способы их получения, фармацевтические композиции, содержащие их и их применение в терапии.
EA201600411A 2013-11-27 2014-11-26 Производные пиперидина для применения при лечении или профилактики психиатрических и неврологических состояний EA030729B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1320905.1A GB201320905D0 (en) 2013-11-27 2013-11-27 Therapeutic compounds
PCT/GB2014/053499 WO2015079224A1 (en) 2013-11-27 2014-11-26 Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

Publications (2)

Publication Number Publication Date
EA201600411A1 true EA201600411A1 (ru) 2016-10-31
EA030729B1 EA030729B1 (ru) 2018-09-28

Family

ID=49918264

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201600411A EA030729B1 (ru) 2013-11-27 2014-11-26 Производные пиперидина для применения при лечении или профилактики психиатрических и неврологических состояний

Country Status (9)

Country Link
US (1) US10562882B2 (ru)
EP (1) EP3074385B1 (ru)
JP (1) JP6537509B2 (ru)
CN (1) CN105793249B (ru)
AU (1) AU2014356233B2 (ru)
CA (1) CA2931778C (ru)
EA (1) EA030729B1 (ru)
GB (1) GB201320905D0 (ru)
WO (1) WO2015079224A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI695831B (zh) 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Ｃｒｔｈ２拮抗劑化合物及其用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT77352A (hu) 1994-08-24 1998-03-30 Astra Aktiebolag Spiro[aza-bicikloalkán-oxazolidin]-2'-on-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE9904176D0 (sv) 1999-11-18 1999-11-18 Astra Ab New use
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
KR20030026979A (ko) * 2000-07-18 2003-04-03 야마노우치세이야쿠 가부시키가이샤 디시아노피리딘 유도체를 포함하는 의약
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
CA2446326C (en) 2001-05-18 2010-12-07 Astrazeneca Ab 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
DK1397366T3 (da) 2001-06-01 2007-05-07 Astrazeneca Ab Hidtil ukendt ligander for nicotinacetylcholinreceptorer egnede i terapi
CA2482312A1 (en) 2002-04-18 2003-10-23 Astrazeneca Ab Thienyl compounds
MXPA04010191A (es) 2002-04-18 2005-02-03 Astrazeneca Ab Compuestos de furilo.
JP4523775B2 (ja) 2002-04-18 2010-08-11 アストラゼネカ・アクチエボラーグ 複素環化合物
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
EP1562908A1 (en) * 2002-11-12 2005-08-17 Pfizer Products Inc. Quinoline derivatives
US7632950B2 (en) * 2003-08-18 2009-12-15 Fujifilm Finechemicals Co., Ltd Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them
JP2007532676A (ja) * 2004-04-13 2007-11-15 イカジェン インコーポレイテッド カリウムイオンチャネル調節剤としての多環式ピリジン
WO2007062120A2 (en) * 2005-11-23 2007-05-31 Apneon, Inc. Devices, systems, and methods for stabilization or fixation of magnetic force devices used in or on a body
JP5452934B2 (ja) * 2005-12-29 2014-03-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ プロキネチシン１受容体アンタゴニスト
CA2635845A1 (en) 2005-12-29 2007-07-12 Janssen Pharmaceutica N.V. Prokineticin 2 receptor antagonists
US7964728B2 (en) * 2006-07-06 2011-06-21 Solvay Pharmaceuticals B.V. Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
AR061808A1 (es) * 2006-07-06 2008-09-24 Solvay Pharm Bv Derivados de azaindol con una combinacion de agonismo parcial del receptor nicotinico acetilcolina e inhibicion de la reabsorcion de dopamina
US7947689B2 (en) 2006-08-04 2011-05-24 Merz Pharma Gmbh & Co. Kgaa Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators
US8722896B2 (en) * 2008-12-17 2014-05-13 The Regents Of The University Of California Prokineticin receptor antagonists and uses thereof
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
EP3082802B1 (en) * 2013-12-03 2020-02-26 Iomet Pharma Ltd. Tryptophan-2,3-dioxygenase (tdo) and/or indolamine-2,3-dioxygenase (ido) inhibitors and their use

Also Published As

Publication number Publication date
JP6537509B2 (ja) 2019-07-03
AU2014356233B2 (en) 2018-10-25
EA030729B1 (ru) 2018-09-28
CN105793249B (zh) 2019-09-24
AU2014356233A1 (en) 2016-05-12
GB201320905D0 (en) 2014-01-08
EP3074385B1 (en) 2021-12-22
CN105793249A (zh) 2016-07-20
US10562882B2 (en) 2020-02-18
US20170166553A1 (en) 2017-06-15
EP3074385A1 (en) 2016-10-05
CA2931778A1 (en) 2015-06-04
WO2015079224A1 (en) 2015-06-04
CA2931778C (en) 2022-05-10
JP2016538294A (ja) 2016-12-08

Similar Documents

Publication Publication Date Title
CY1123595T1 (el) Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
PH12018500040A1 (en) Indazole and azaindazole compounds as irak-4 inhibitors
PH12017500276A1 (en) Aminopyrimidinyl compounds as jak inhibitors
EA201891063A1 (ru) Производные дигидроимидазопиразинона, применимые в лечении рака
EA201650031A1 (ru) Производные пирролидин-2,5-диона, фармацевтические композиции и способы применения в качестве ингибиторов ido1
MY202022A (en) Pyrrolotriazine compounds as tam inhibitors
PH12016502378A1 (en) Substituted dihydroisoquinolinone compounds
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2015011984A (es) Inhibidores de bromodominio de dihidro-pirrolopiridinona.
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
EA201590228A1 (ru) Антагонисты 5-ht3 рецептора
EA201792425A1 (ru) Трициклические соединения и их применение в качестве ингибиторов фосфодиэстераз
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
CY1122077T1 (el) Νεα δακτυλιωμενα φαινοξυακεταμιδια
EA201692300A1 (ru) Производные карбоксамида
PH12017501876A1 (en) Pyridopyrimidones and their use as nmda receptor modulators
MX382175B (es) Composiciones de profármaco de monometilfumarato
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
EA201650003A1 (ru) Соединённые циклоалкилом дигетероциклические производные
EA201600002A1 (ru) Производные пролекарства замещенных триазолопиридинов
EA201600166A1 (ru) Производные пиперидина и азепина как модуляторы рецептора прокинетицина
EA201792265A1 (ru) Способы лечения сердечно-сосудистых заболеваний

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM